HSCT recipients have specific tolerance to MSC but not to the MSC donor

Multipotent mesenchymal stromal cells (MSC) are increasingly used to treat refractory graft-versus-host-disease and other complications following hematopoietic stem cell transplantation (HSCT). We evaluated immunogenicity of HLA-mismatched MSC infused post-transplant to HSCT recipients. Recipient ly...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Sundin, Mikael, Barrett, A. John, Ringdén, Olle, Uzunel, Mehmet, Lönnies, Helena, Dackland, Åsa-Lena, Christensson, Birger, Le Blanc, Katarina
Médium: Artigo
Jazyk:Inglês
Vydáno: 2009
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2747778/
https://ncbi.nlm.nih.gov/pubmed/19561533
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CJI.0b013e3181ab1807
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky